Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemorrhoidal Artery Embolization: Longitudinal Impact On Symptoms (HELIOS)

NCT07179601 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT07179601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07179601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemorrhoidal Artery Embolization: Longitudinal Impact On Symptoms (HELIOS)
Lead sponsor
University of California, Los Angeles
Phase
Not applicable
Overall status
Recruiting
Start date
August 5, 2025
Completion date
September 30, 2029
Enrollment
22 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hae, internal hemorrhoids